Table 2.
Determination of proteinase and phospholipase production, cell surface hydrophobicity, and cell membrane ergosterol content in Candida albicans treated with Carum carvi essential oil and fluconazole
| Groups | Proteinase production (mm) | Proteinase inhibition (%) | Phospholipase production (mm) | Phospholipase inhibition (%) | CSH (%) | CME (µg/g) | CME Inhibition (%) |
|---|---|---|---|---|---|---|---|
| C. carvi EO -treated | 1.43±0.07 | 49.8 | 0.93±0.02 | 53.26 | 12.75 | 0.084±0.01 | 25.74 |
| Fluconazole -treated | 2.06±0.05 | 27.72 | 1.30±0.08 | 34.67 | 20.80 | 0.064±0.01 | 43.36 |
| Control (Non-treated) | 2.85± 0.15 | 00.00 | 1.99±0.10 | 00.00 | 38.98 | 0.113±0.01 | 00.00 |
Results of the mean±SD of two experiments, each in triplicate.
CSH: cell surface hydrophobicity, CME: cell membrane ergosterol